XBI biotech index rises, giving investors a shred of hope

Off Biotech, biotechnology, drug development, drug prices, drug pricing, finance, Health, health care, Human Health, Life Sciences, Medicine, Pharma, public health, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Happy Monday. So, we’ve got a welcome bump in the XBI, see that European regulatory conditions are prompting Ozempic maker Novo Nordisk to look stateside for growth, and more.

Read the rest…

Read Original Article: XBI biotech index rises, giving investors a shred of hope »

About The Author